'Important to distinguish between what's medicine and what's not' in cannabis: GW Pharma CEO

7:24 PM ET Thu, 1 Nov 2018

Jim Cramer hears from GW Pharmaceuticals CEO Justin Gover about his company's cannabis-based epilepsy treatment that just launched in the United States.